Stay informed: news & events from Miltenyi Bioindustry

Explore the latest updates and event highlights from Miltenyi Bioindustry. Stay connected to drive the future of biomanufacturing and discover upcoming opportunities to engage with us.

News

September 10, 2024
Miltenyi Biotec manufactures lentiviral vector for Adaptimmune’s FDA-approved TCR T-cell therapy TECELRA® (afamitresgeme autoleucel) | Read the full press release

Events

BIO 2025
Meet us at the Boston Convention & Exhibition Center
June 16-19, 2025, Boston, USA